FDA Approved: TASCENSO ODT — Supplemental Application (Cycle Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for Tasenso ODT (fingolimod lauryl sulfate), introducing a new orodispersible tablet formulation of fingolimod. The prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)

Snippet

SUPPL AP for TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)